XML 17 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
5. Stockholders' Equity
9 Months Ended
Mar. 31, 2017
Equity [Abstract]  
Stockholders' Equity

Stock Incentive Plans

 

Our stock incentive plans permit the granting of stock options (both incentive and nonqualified stock options), restricted stock units (“RSUs”), stock appreciation rights, non-vested stock, and performance shares to certain employees, directors and consultants. As of March 31, 2017, no stock appreciation rights, non-vested stock, or performance shares were outstanding.

 

Stock Options

  

The following table presents a summary of activity during the nine months ended March 31, 2017 with respect to our stock options:

 

       Weighted- 
       Average 
   Number of   Exercise Price 
   Shares   per Share 
   (In thousands) 
Balance of options outstanding at June 30, 2016   3,606   $1.85 
Granted   864    1.61 
Forfeited   (45)   1.42 
Expired   (74)   4.22 
Exercised   (99)   1.85 
Balance of options outstanding at March 31, 2017   4,252   $1.77 

  

Restricted Stock Units

 

The following table presents a summary of activity during the nine months ended March 31, 2017 with respect to our RSUs:

 

       Weighted- 
       Average 
       Grant Date 
   Number of   Fair Value 
   Shares   per Share 
   (In thousands)     
Balance of RSUs outstanding at June 30, 2016   460   $1.10 
Granted   85    1.81 
Vested   (198)   1.10 
Cancelled / forfeited        
Balance of RSUs outstanding at March 31, 2017   347   $1.27 

 

During the nine months ended March 31, 2017, a total of 187,500 RSUs vested pursuant to a RSU grant made in April 2016 to Jeffrey Benck, our chief executive officer. In connection with the vesting of these RSUs, we issued approximately 112,000 shares of our common stock to Mr. Benck, and withheld the remaining approximately 76,000 shares for purposes of employee payroll taxes.

 

Employee Stock Purchase Plan 

 

Our 2013 Employee Stock Purchase Plan (the “ESPP”) is intended to provide employees with an opportunity to purchase our common stock through accumulated payroll deductions at the end of a specified purchase period. Each of our employees (including officers) is eligible to participate in the ESPP, subject to certain limitations as set forth in the ESPP.

 

The following table presents a summary of activity under our ESPP during the nine months ended March 31, 2017:

 

   Number of 
   Shares 
   (In thousands) 
Shares available for issuance at June 30, 2016   736 
Shares issued   (113)
Shares available for issuance at March 31, 2017   623 

 

Share-Based Compensation Expense

 

The following table presents a summary of share-based compensation expense included in each functional line item on our unaudited condensed consolidated statements of operations:

 

   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2017   2016   2017   2016 
   (In thousands) 
Cost of revenue  $12   $14   $36   $52 
Selling, general and administrative   169    131    480    484 
Research and development   43    41    129    135 
Total share-based compensation expense  $224   $186   $645   $671 

 

 

The following table presents the remaining unrecognized share-based compensation expense related to our outstanding share-based awards as of March 31, 2017:

 

   Remaining   Remaining 
   Unrecognized   Weighted- 
   Compensation   Average Years 
   Expense   To Recognize 
   (In thousands)     
Stock options  $1,395    3.0 
RSUs   408    2.8 
Stock purchase rights under ESPP   128    1.1 

 

If there are any modifications or cancellations of the underlying unvested share-based awards, we may be required to accelerate, increase or cancel remaining unearned share-based compensation expense. Future share-based compensation expense and unearned share-based compensation will increase to the extent that we grant additional share-based awards.